bevacizumab

Bevacizumab (trade name Avastin) is a monoclonal antibody against vascular endothelial growth factor. It is used in the treatment of cancer, where it inhibits tumor growth by blocking the formation of new blood vessels. Bevacizumab was the first clinically available angiogenesis inhibitor in the United States.
See more at Wikipedia.org...

Bevacizumab Warning - High-alert drug! Avastin Pharmacologic class: Monoclonal antibody Therapeutic class: Immunologic agent Pregnancy risk category [more]Bevacizumab - Community and Resources

[be-vuh-SIZ-uh-mab]
A monoclonal antibody used in the treatment of colorectal cancer that has spread. It is also being studied in the treatment of other types of cancer. It may prevent the growth of new blood vessels from surrounding tissue to a solid tumor. Also called Avastin.